ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
135 hedge funds and large institutions have $377M invested in iTeos Therapeutics in 2025 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 57 increasing their positions, 30 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 131 → 135 (+4)
2% more ownership
Funds ownership: 96.8% → 98.8% (+2%)
3% less call options, than puts
Call options by funds: $8.46M | Put options by funds: $8.73M
Holders
135
Holding in Top 10
4
Calls
$8.46M
Puts
$8.73M
Top Buyers
| 1 | +$107M | |
| 2 | +$11.3M | |
| 3 | +$8.23M | |
| 4 |
O
OrbiMed
New York
|
+$6.98M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$5.95M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$18.4M | |
| 3 | -$16.4M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$13.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$10.8M |
